US Patent Issued to Novartis on July 15 for "NMDA receptor modulators and uses thereof" (Connecticut, Massachusetts Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,929, issued on July 15, was assigned to Novartis AG (Basel, Switzerland).

"NMDA receptor modulators and uses thereof" was invented by David R. Anderson (Salem, Conn.), Robert A. Volkmann (Mystic, Conn.), Frank S. Menniti (Mystic, Conn.), Christopher Fanger (Bolton, Mass.) and Yuelian Xu (East Haven, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein, in part, are heteroaromatic compounds and methods of use in treating neuropsychiatric disorders, e.g., schizophrenia and major depressive disorder. Pharmaceutical compositions and methods of making heteroaromatic compounds are provided. The compounds are contemplated to modulate the N...